What is the lab value for bioavailable testosterone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bioavailable Testosterone Lab Values

The lower normal limit for bioavailable testosterone in adult men is approximately 2.30-2.72 nmol/L (66-78 ng/dL) when measured by ammonium sulfate precipitation, based on a large reference population of healthy men aged 20-74 years. 1

Reference Ranges by Measurement Method

Measured Bioavailable Testosterone (Direct Assay)

  • Lower normal limit: 2.30-2.72 nmol/L in men ≤39 years old 1
  • This represents the assayed bioavailable testosterone (aBT) after ammonium sulfate precipitation, which is considered the reference method 1
  • Values decline with age, with significant decreases observed in older populations 1

Calculated Bioavailable Testosterone

  • Calculated values vary substantially depending on the algorithm used 2
  • Mean calculated bioavailable testosterone ranges from 3.87 to 10.4 nmol/L depending on which published algorithm is applied 2
  • The Sodergard algorithm produces the highest values (mean 10.4 nmol/L), while the Emadi-Konjin algorithm produces the lowest (mean 3.87 nmol/L) 2
  • Calculated bioavailable testosterone at a threshold of 0.78 nmol/L showed diagnostic utility in PCOS studies (sensitivity 0.76, specificity 0.83), though this population differs from adult males 3

Clinical Context for Interpretation

When to Measure Bioavailable Testosterone

  • Bioavailable testosterone measurement is most useful when total testosterone falls between 6.5-13.0 nmol/L (187-375 ng/dL) 4
  • Outside this range, total testosterone alone provides sufficient diagnostic information 4
  • In men with diabetes who have total testosterone levels close to the lower limit, free or bioavailable testosterone should be measured due to expected decreases in sex hormone-binding globulin 3

Key Measurement Considerations

  • Morning fasting samples are essential for accurate assessment, as testosterone levels fluctuate throughout the day 5
  • Bioavailable testosterone represents unbound testosterone plus albumin-bound testosterone, reflecting the readily dissociable and biologically available fraction 6
  • Only 0.5-3% of circulating testosterone is free, with the remainder bound to SHBG (60%) and albumin (38%) 6

Algorithm Discrepancies and Pitfalls

Calculation Method Variability

  • Different published algorithms produce results that differ by up to 2.7-fold 2
  • The association constants used (Ks for SHBG and Ka for albumin) dramatically affect calculated values 1
  • Standard constants (Ks = 1×10⁹ L/mol, Ka = 3.6×10⁴ L/mol) produce calculated values approximately 2-fold higher than measured values 1
  • Optimized constants (Ks = 1.9×10⁹ L/mol, Ka = 2.45×10⁴ L/mol) provide better correlation with measured values 1

SHBG Confounding

  • Many calculated bioavailable testosterone algorithms remain significantly associated with SHBG concentrations, introducing potential confounding 2
  • Androstenediol (5-diol) acts as a competitive SHBG inhibitor and should be considered in calculations for improved accuracy 1
  • SHBG alterations can significantly affect total testosterone concentrations, making bioavailable testosterone measurement critical in certain clinical scenarios 6

Diagnostic Thresholds in Clinical Practice

Hypogonadism Diagnosis

  • Total testosterone <8 nmol/L (230 ng/dL) highly supports hypogonadism diagnosis 7
  • Total testosterone >12 nmol/L (346 ng/dL) is likely normal 7
  • The "gray zone" of 8-12 nmol/L (230-346 ng/dL) requires evaluation of free or bioavailable testosterone 7
  • This gray zone represents approximately 90% of cases where bioavailable testosterone measurement adds diagnostic value 4

Cost-Effectiveness Strategy

  • Restricting SHBG and bioavailable testosterone measurement to patients with total testosterone between 6.5-13.0 nmol/L enables reagent cost savings exceeding 55% 4
  • Below 6.5 nmol/L or above 13.0 nmol/L, total testosterone provides sufficient information for ruling out hypogonadism 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.